Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper
Anne Smits, Pieter Annaert, Giacomo Cavallaro, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 12, pp. 4965-4984
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Medication Hazards and Outcome Patterns of Pediatric Drug-Associated Liver Injury in Taiwan: An Analysis of 1998–2017 Spontaneous Adverse Drug Reaction Reports
Yuting Huang, Yenming Huang, Ni‐Chung Lee, et al.
Drugs - Real World Outcomes (2025)
Open Access | Times Cited: 1
Mathematical Albumin Function for Neonates Undergoing Therapeutic Hypothermia in Comparison with Control Neonates
Zoë Vander Elst, Thibault Stultjens, Pieter Annaert, et al.
The Journal of Clinical Pharmacology (2025)
Open Access | Times Cited: 1
Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials
Cindy Hoi Ting Yeung, Ruud H J Verstegen, Rachel G. Greenberg, et al.
Frontiers in Pediatrics (2024) Vol. 11
Open Access | Times Cited: 5
Emerging Trends and Transdisciplinary Approaches in Autism Spectrum Disorder Management
Umar Ishaq, Hamza Ishaq
IGI Global eBooks (2025), pp. 163-182
Closed Access
What Is New in Psychiatry and Psychopharmacology
Donatella Marazziti
Life (2025) Vol. 15, Iss. 2, pp. 220-220
Open Access
Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine
Matthias Gijsen, Dirk Vlasselaers, Isabel Spriet, et al.
Antibiotics (2021) Vol. 10, Iss. 10, pp. 1182-1182
Open Access | Times Cited: 28
Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates
Angeliki Kontou, Maria Kourti, Εlias Iosifidis, et al.
Antibiotics (2023) Vol. 12, Iss. 6, pp. 1072-1072
Open Access | Times Cited: 9
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians
Kevin Meesters, Violeta Balbas‐Martinez, Karel Allegaert, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 4, pp. 365-379
Closed Access | Times Cited: 3
The Blind Spot of Pharmacology: A Scoping Review of Drug Metabolism in Prematurely Born Children
Mette Louise Mørk, Jón Trærup Andersen, Ulrik Lausten‐Thomsen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Clinical Pharmacology
Richard Woolf, Catherine Smith
(2024), pp. 1-14
Closed Access | Times Cited: 2
Value of preclinical systematic reviews and meta-analyses in pediatric research
Olga Romantsik, Matthias Bank, Julia M. L. Menon, et al.
Pediatric Research (2024) Vol. 96, Iss. 3, pp. 643-653
Open Access | Times Cited: 2
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children
Katharine Cheng, Fenna Mahler, Irja Lutsar, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 3, pp. 478-488
Open Access | Times Cited: 12
Current and future physiologically based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonates
Karel Allegaert, Mohammad Yaseen Abbasi, Pieter Annaert, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 5, pp. 301-312
Open Access | Times Cited: 10
Massive presence of off‐label medicines in Danish neonatal departments: A nationwide survey using national hospital purchase data
Christina Gade, Stine Trolle, Mette‐Louise Mørk, et al.
Pharmacology Research & Perspectives (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Machine Learning: A Potential Therapeutic Tool to Facilitate Neonatal Therapeutic Decision Making
Bo-Hao Tang, Qiu‐Yue Li, Hui‐Xin Liu, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 4, pp. 355-363
Closed Access | Times Cited: 1
Drug related adverse event assessment in neonates in clinical trials and clinical care
Nadir Yalçın, John van den Anker, Samira Samiee‐Zafarghandy, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 9, pp. 803-816
Closed Access | Times Cited: 1
Optimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient‐CEntric ClinicAl TRial PLatforms
Britt A. E. Dhaenens, Fenna Mahler, Hannah Batchelor, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 8, pp. 1458-1468
Open Access | Times Cited: 4
Theoretical medicine: the foundation of the future of medicine
Bohdan Lysetskyi, Olena Vesova, Ihor Kindras, et al.
Futurity Medicine. (2024), pp. 45-56
Open Access | Times Cited: 1
Going the Extra Mile: Why Clinical Research in Cystic Fibrosis Must Include Children
Rebecca Dobra, Siân Bentley, C. Edmondson, et al.
Children (2022) Vol. 9, Iss. 7, pp. 1080-1080
Open Access | Times Cited: 7
A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study
Sagar S. Bachhav, Maxine Taylor, Ana Belén Barragán Martín, et al.
British Journal of Clinical Pharmacology (2022) Vol. 89, Iss. 3, pp. 1187-1197
Open Access | Times Cited: 7
Use of Newer and Repurposed Antibiotics Against Gram-negative Bacteria in Neonates
Angeliki Kontou, Maria Kourti, Εlias Iosifidis, et al.
(2023)
Open Access | Times Cited: 3
Therapeutic drug monitoring-guided dosing for pediatric cystic fibrosis patients: recent advances and future outlooks
Siân Bentley, Jamie Cheong, Nikesh Gudka, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 8, pp. 715-726
Closed Access | Times Cited: 3
Grading the level of evidence of neonatal pharmacotherapy: midazolam and phenobarbital as examples
Liam Mahoney, Genny Raffaeli, Serdar Beken, et al.
Pediatric Research (2023) Vol. 95, Iss. 1, pp. 75-83
Closed Access | Times Cited: 3
Pragmatic physiologically-based pharmacokinetic modeling to support clinical implementation of optimized gentamicin dosing in term neonates and infants: proof-of-concept
Marika A. de Hoop‐Sommen, Joyce E. M. van der Heijden, Jolien J. M. Freriksen, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top